Cargando…

Edaravone Attenuated Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice

Background: The aim of the study was to define whether edaravone, a free-radical scavenger, influenced angiotensin II (AngII)-induced atherosclerosis and abdominal aortic aneurysms (AAAs) formation. Methods: Male apolipoprotein E-deficient mice (8–12 weeks old) were fed with a normal diet for 5 week...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uchida, Haruhito A., Takatsuka, Tetsuharu, Hada, Yoshiko, Umebayashi, Ryoko, Takeuchi, Hidemi, Shikata, Kenichi, Subramanian, Venkateswaran, Daugherty, Alan, Wada, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405883/ https://www.ncbi.nlm.nih.gov/pubmed/36009011 http://dx.doi.org/10.3390/biom12081117

Ejemplares similares

Exogenous Vasohibin-2 Exacerbates Angiotensin II-Induced Ascending Aortic Dilation in Mice
por: Okuyama, Michihiro, et al.
Publicado: (2019)

Cilostazol Attenuates AngII-Induced Cardiac Fibrosis in apoE Deficient Mice
por: Hada, Yoshiko, et al.
Publicado: (2022)

The Association of Postprandial Triglyceride Variability with Renal Dysfunction and Microalbuminuria in Patients with Type 2 Diabetic Mellitus: A Retrospective and Observational Study
por: Matsuoka-Uchiyama, Natsumi, et al.
Publicado: (2022)

Abdominal aortic aneurysm in aged population
por: Umebayashi, Ryoko, et al.
Publicado: (2018)

Report of health checkup system for chronic kidney disease in general population in Okayama city: effect of health guidance intervention on chronic kidney disease outcome
por: Kakio, Yuki, et al.
Publicado: (2019)

Chronic Kidney Disease Is Positively and Diabetes Mellitus Is Negatively Associated with Abdominal Aortic Aneurysm
por: Takeuchi, Hidemi, et al.
Publicado: (2016)

The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients
por: Takeuchi, Hidemi, et al.
Publicado: (2018)

Fisetin Attenuates Lipopolysaccharide-Induced Inflammatory Responses in Macrophage
por: Hada, Yoshiko, et al.
Publicado: (2021)

The Protective Effect of Chlorogenic Acid on Vascular Senescence via the Nrf2/HO-1 Pathway
por: Hada, Yoshiko, et al.
Publicado: (2020)

Prevalence of Chronic Kidney Disease and Variation of Its Risk Factors by the Regions in Okayama Prefecture
por: Umebayashi, Ryoko, et al.
Publicado: (2022)

Calpain-2 Compensation Promotes Angiotensin II-Induced Ascending and Abdominal Aortic Aneurysms in Calpain-1 Deficient Mice
por: Subramanian, Venkateswaran, et al.
Publicado: (2013)

Editorial: Advanced research on abdominal and thoracic aortic aneurysms: new insights into molecular mechanisms
por: Subramanian, Venkateswaran, et al.
Publicado: (2023)

Dysfunction of CD8 + PD-1 + T cells in type 2 diabetes caused by the impairment of metabolism-immune axis
por: Nojima, Ichiro, et al.
Publicado: (2020)

Effects of Endogenous Angiotensin II on Abdominal Aortic Aneurysms and Atherosclerosis in Angiotensin II–Infused Mice
por: Kukida, Masayoshi, et al.
Publicado: (2021)

Angiopoietin-2 attenuates angiotensin II-induced aortic aneurysm and atherosclerosis in apolipoprotein E-deficient mice
por: Yu, Hongyou, et al.
Publicado: (2016)

The possible involvement of intestine-derived IgA(1): a case of IgA nephropathy associated with Crohn’s disease
por: Terasaka, Tomohiro, et al.
Publicado: (2016)

Combination of Renal Angioplasty and Angiotensin-converting-enzyme Inhibitor Can Reduce Proteinuria in Patients with Bilateral Renal Artery Disease
por: Toda, Hironobu, et al.
Publicado: (2019)

Cholecystokinin Plays a Novel Protective Role in Diabetic Kidney Through Anti-inflammatory Actions on Macrophage: Anti-inflammatory Effect of Cholecystokinin
por: Miyamoto, Satoshi, et al.
Publicado: (2012)

The Beneficial Effect of Personalized Lifestyle Intervention in Chronic Kidney Disease Follow-Up Project for National Health Insurance Specific Health Checkup: A Five-Year Community-Based Cohort Study
por: Takeuchi, Hidemi, et al.
Publicado: (2022)

The Effect of Soluble RAGE on Inhibition of Angiotensin II-Mediated Atherosclerosis in Apolipoprotein E Deficient Mice
por: Lee, Dajeong, et al.
Publicado: (2013)

Renal Denervation Promotes Atherosclerosis in Hypertensive Apolipoprotein E-Deficient Mice Infused with Angiotensin II
por: Wang, Yutang, et al.
Publicado: (2017)

Association between Urinary Creatinine Excretion and Hypothyroidism in Patients with Chronic Kidney Disease
por: Matsuoka-Uchiyama, Natsumi, et al.
Publicado: (2023)

Circadian disruption with constant light exposure exacerbates atherosclerosis in male ApolipoproteinE-deficient mice
por: Chalfant, Jeffrey M., et al.
Publicado: (2020)

Retraction: The Effect of Soluble RAGE on Inhibition of Angiotensin II-Mediated Atherosclerosis in Apolipoprotein E Deficient Mice
por: Lee, Dajeong, et al.
Publicado: (2014)

Genetic Variants of the Renin Angiotensin System: Effects on Atherosclerosis in Experimental Models and Humans
por: Daugherty, Alan, et al.
Publicado: (2010)

Chronic environmental circadian disruption increases atherosclerosis and dyslipidemia in female, but not male, ApolipoproteinE-deficient mice
por: Chalfant, Jeffrey M., et al.
Publicado: (2023)

Insufficient control of morning home blood pressure in Japanese patients with hypertension associated with diabetes mellitus
por: Uchida, Haruhito A., et al.
Publicado: (2010)

Chronic kidney disease is associated with carotid atherosclerosis and symptomatic ischaemic stroke
por: Kajitani, Nobuo, et al.
Publicado: (2018)

The association between hypothyroidism and proteinuria in patients with chronic kidney disease: a cross-sectional study
por: Matsuoka-Uchiyama, Natsumi, et al.
Publicado: (2022)

Edaravone: a baby in the bathwater?
por: Ludolph, Albert
Publicado: (2017)

Edaravone Enhances Brain-Derived Neurotrophic Factor Production in the Ischemic Mouse Brain
por: Okuyama, Satoshi, et al.
Publicado: (2015)

Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor
por: Zhang, Wei-Wei, et al.
Publicado: (2017)

Case of emphysematous cholecystitis in a patient with type 2 diabetes mellitus associated with schizophrenia
por: Ogawa, Ayu, et al.
Publicado: (2012)

Inhibition of angiotensin-induced aortic aneurysm by metformin in apolipoprotein E–deficient mice
por: Kunath, Anne, et al.
Publicado: (2021)

Association with inflammatory cells and apolipoproteins to the progression of atherosclerosis
por: Eo, Hyun-Seon, et al.
Publicado: (2011)

Role of edaravone in managemant of septic peritonitis
por: Elbaradey, Ghada Fouad, et al.
Publicado: (2016)

Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
por: Shi, Fenghao, et al.
Publicado: (2022)

Combination therapy with an angiotensin‐converting‐enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy
por: Nakamura, Akihiko, et al.
Publicado: (2012)

Effect of Apolipoprotein E ε4 Allele on the Progression of Carotid Atherosclerosis Through Apolipoprotein Levels
por: Ma, Wenbing, et al.
Publicado: (2022)

Edaravone combined with Shuxuening versus edaravone alone in the treatment of acute cerebral infarction: A systematic review and meta-analysis
por: Li, Liang-Da, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v6dv5n2q4e2ur49dnqhk5l12su